Abstract:Background: Several studies suggested an important role of the gut microbiota in the pathophysiology of neurological disorders, implying that alteration of the gut microbiota might serve as a treatment strategy. Fecal microbiota transplantation (FMT) is currently the most effective gut microbiota intervention and an accepted treatment for recurrent Clostridioides difficile infections. To evaluate indications of FMT for patients with neurological disorders, we summarized the available literature on FMT. In addition, we provide suggestions for future directions.Methods: In July 2019, five main databases were searched for studies and case descriptions on FMT in neurological disorders in humans or animal models. In addition, the <a href="https://www.ClinicalTrials.gov">ClinicalTrials.gov</a> website was consulted for registered planned and ongoing trials.Results: Of 541 identified studies, 34 were included in the analysis. Clinical trials with FMT have been performed in patients with autism spectrum disorder and showed beneficial effects on neurological symptoms. For multiple sclerosis and Parkinson's disease, several animal studies suggested a positive effect of FMT, supported by some human case reports. For epilepsy, Tourette syndrome, and diabetic neuropathy some studies suggested a beneficial effect of FMT, but evidence was restricted to case reports and limited numbers of animal studies. For stroke, Alzheimer's disease and Guillain-Barré syndrome only studies with animal models were identified. These studies suggested a potential beneficial effect of healthy donor FMT. In contrast, one study with an animal model for stroke showed increased mortality after FMT. For Guillain-Barré only one study was identified. Whether positive findings from animal studies can be confirmed in the treatment of human diseases awaits to be seen. Several trials with FMT as treatment for the above mentioned neurological disorders are planned or ongoing, as well as for amyotrophic lateral sclerosis.Conclusions: Preliminary literature suggests that FMT may be a promising treatment option for several neurological disorders. However, available evidence is still scanty and some contrasting results were observed. A limited number of studies in humans have been performed or are ongoing, while for some disorders only animal experiments have been conducted. Large double-blinded randomized controlled trials are needed to further elucidate the effect of FMT in neurological disorders.

Fecal microbiota transplantation in the treatment of hepatic encephalopathy: A perspective

Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment

Navigating the Gut-brain Axis: Insights into the Pathogenesis of Hepatic Encephalopathy

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy

Nonpharmacologic Management of Hepatic Encephalopathy: An Update

Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain

Fecal microbiota transplantation: in perspective

New perspective on fecal microbiota transplantation in liver diseases

An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases

Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis

Comparisons of efficacy and safety of 400 or 800 ml bacterial count fecal microbiota transplantation in the treatment of recurrent hepatic encephalopathy: a multicenter prospective randomized controlled trial in China

Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives

Clinical Application and Potential of Fecal Microbiota Transplantation

Fecal microbiota transplantation: current challenges and future landscapes

Hepatic encephalopathy: From novel pathogenesis mechanism to emerging treatments

Fecal Microbiota Transplantation in Neurological Disorders

Nontraditional Treatment of Hepatic Encephalopathy

Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain